23 Nov: Markets rangebound; conflicting headlines keep traders sidelined. Flash PMIs in focus, Monday. US Thanksgiving, Thursday.

Both the FX and stock markets ended the week on a mostly quiet note, generally within their familiar ranges as traders struggle to find clarity over the contradicting headlines regarding…

Continue Reading 23 Nov: Markets rangebound; conflicting headlines keep traders sidelined. Flash PMIs in focus, Monday. US Thanksgiving, Thursday.

20 Nov: Stocks, FX rangebound as lockdown concerns/vaccine hopes contest for upper hand. Australian R/S ahead. G20; Riyadh, Sat/Sun

Both the FX and the stock markets are more or less flat at the end of Thursday trade as traders balance out the concerns of mounting Covid-inspired shutdowns and layoffs…

Continue Reading 20 Nov: Stocks, FX rangebound as lockdown concerns/vaccine hopes contest for upper hand. Australian R/S ahead. G20; Riyadh, Sat/Sun

19 Nov: Stocks flat, US$ heavy despite further positve vaccine news. Australian Jobs data ahead today.

Further good news on the pandemic was unable to help US stocks on Wednesday, with the major indices ending down by around 0.25%, apparently fully pricing in the chances of…

Continue Reading 19 Nov: Stocks flat, US$ heavy despite further positve vaccine news. Australian Jobs data ahead today.

18 Nov: Stocks, US$ ease after soft R/S figures. Powell says recovery has significant downside risks in near term. Wednesday focus: EU/UK CPI.

The US$ and the main US stock indices have dipped on Tuesday, with both the S&P and the DJI retreating from Monday’s all-time highs following some  disappointing retail sales data…

Continue Reading 18 Nov: Stocks, US$ ease after soft R/S figures. Powell says recovery has significant downside risks in near term. Wednesday focus: EU/UK CPI.

17 Nov: Risk sentiment underpinned by more positve vaccine headlines. RBA Minutes ahead. US R/S, I/P, C/U & NAHB all due later.

Risk-sentiment remains positive on Tuesday, underpinned by some more good news on the coronavirus vaccine, with the announcement from Moderna Inc; who said that its vaccine was shown to be…

Continue Reading 17 Nov: Risk sentiment underpinned by more positve vaccine headlines. RBA Minutes ahead. US R/S, I/P, C/U & NAHB all due later.